- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03234166
Acute Necrotizing Pancreatitis and Infected Pancreatic Necrosis (PANIC)
April 20, 2022 updated by: Nantes University Hospital
Acute Necrotizing Pancreatitis and Infected Pancreatic Necrosis: Can we Predict Primary Drainage Failure?
Acute necrotizing pancreatitis is a frequent and potentially lethal disease, especially in case of infected pancreatic necrosis (IPN).
IPN usually occurs after the first week of evolution.
The step up approach is now widely recommended for the management of IPN.
In fact, in case of suspicion of IPN, a drainage percutaneous or transgastric is recommended at first, supported by probabilist antibiotherapy.
1/3 of patients won't require any other interventions.
For 2/3 of patients, an additional necrosectomy is necessary.
Necrosectomy was formally realized by open laparotomy.
Since de last decade, mini-invasive technics have emerged: transgastric necrosectomy, video-assist retroperitoneal debridement.
laparoscopy and permitted a decreased of morbidity and mortality.
Recently, Hollemans et al. developed a nomogram based on 4 variables (sex, multi-organ failure, % of necrosis and collections heterogeneity) which are negative predictors for success of catheter drainage in IPN with an receiver operating characteristic (ROC) curve at 0.76.
The aim of this study is to validate on a large retrospective cohort Hollemans nomogram in predicting catheter drainage success.
Secondary aims are to evaluate possible others predictors for success of catheter drainage in IPN and to evaluate the impact of antibiotherapy on microbiological results and on the need for an additional necrosectomy regarding its type and duration, as well as the emergence of multiresistance organism.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Using electronic patient data monitoring systems, the investigators reviewed all patients with a diagnosis of acute necrotizing pancreatitis admitted to digestive liver disease unity or ICUs at the Nantes University Hospital, Rennes, Angers and Brest University Hospital from January 1, 2012, to december 31, 2017.
For enrolled patients, general clinical characteristics were collected.
Patients were categorized into two groups according to success of catheter drainage or failure of catheter drainage, and the differences of these characteristics between two groups were evaluated.
The Hollemans nomogram is evaluate and potential risk factors will be collected and studied by using multiple logistic regression analysis.
Study Type
Observational
Enrollment (Actual)
72
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France, 49100
- Angers University Hospital
-
Brest, France, 29200
- Brest University Hospital
-
Nantes, France, 44093
- Nantes University Hospital
-
Rennes, France, 35033
- Rennes University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Major patient, hospitalized with a diagnosis of acute necrotizing pancreatitis between 2012 and 2016, whatever the etiology, complicated by a necrosis infection infection (either proven or strongly suspected) requiring the initiation of antibiotic therapy and a drainage gesture of this CCM.
Description
Inclusion Criteria:
- Adult patients (age >18 years) with acute necrotizing pancreatitis
- IPN proven or highly suspected (proven=positive cultures on pancreatic collections or gas on CT, highly suspected= sepsis without any others infection)
- The need for a catheter drainage
Non inclusion Criteria:
- patients under 18 years
- lack of radiologic evidence to diagnose acute necrotizing pancreatitis,
- no suspicion or confirmation of IPN
- no need for a drainage
- unable to receive a drainage
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ROC curve of Hollemans nomogram
Time Frame: up to 4 months
|
Nomogram based on 4 variables independently associated with success of catheter drainage: Male sex, multiple organ failure, increasing percentage of pancreatic necrosis and heterogeneity of the collection .
Points are awarded to a factor if it is associated with a reduced success chance of catheter drainage.
Favorable scores for all factors (ie, 0 points), result in a 91% success chance of primary catheter drainage.
Similarly, unfavorable scores (maximum of 40 points) result in a 2% success chance of primary catheter drainage.
|
up to 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Potential Predictors of catheter drainage failure
Time Frame: up to 4 months
|
Potential risk factors included patient demographics, disease severity, complications, morphology on CT, and details of the drainage procedure.
Univariate analyses examined potential risk factors on outcome (catheter drainage failure).
Then, using multiple logistic regression analysis, factors achieving P≤0.1 in univariate analyses were entered into the model predicting the risk of catheter drainage failure
|
up to 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2018
Primary Completion (Actual)
March 1, 2019
Study Completion (Actual)
March 1, 2019
Study Registration Dates
First Submitted
July 26, 2017
First Submitted That Met QC Criteria
July 26, 2017
First Posted (Actual)
July 31, 2017
Study Record Updates
Last Update Posted (Actual)
April 28, 2022
Last Update Submitted That Met QC Criteria
April 20, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC17_0246
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Necrotizing Pancreatitis
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Tianjin Nankai HospitalCompletedAcute PancreatitisChina
-
Northern State Medical UniversityCompleted
-
Erzhen ChenRenJi HospitalUnknownPancreatitis,Acute NecrotizingChina
-
Orlando Health, Inc.Mayo Clinic; University of Alabama at Birmingham; University of Southern California and other collaboratorsActive, not recruitingPancreatitis,Acute NecrotizingUnited States
-
University of OuluCopenhagen University Hospital, HvidovreUnknownAcute Necrotizing PancreatitisFinland
-
Sichuan Academy of Medical SciencesPeking Union Medical College HospitalCompleted
-
John Gasdal KarstensenCompleted
-
Asian Institute of Gastroenterology, IndiaCompletedAcute Pancreatitis NecrotizingIndia
-
Sanjay Gandhi Postgraduate Institute of Medical...Recruiting
Clinical Trials on Non interventional study
-
Universitätsklinikum Hamburg-EppendorfSandozUnknownPsoriasisDenmark, Spain, Germany, Poland
-
University Hospital, RouenRecruitingDyspepsia | Irritable Bowel Syndrome | Functional Constipation | Faecal IncontinenceFrance
-
Mayo ClinicRecruitingProstate Adenocarcinoma | Prostate CarcinomaUnited States
-
Algalarrondo VincentBichat Hospital; BioquantisRecruitingTransthyretin Cardiac Amyloidosis | Transthyretin Amyloid Cardiomyopathy | Amyloid CardiomyopathyFrance
-
Mayo ClinicRecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Not yet recruitingPancreatic CarcinomaUnited States
-
Mayo ClinicRecruitingBreast Carcinoma | Recurrent Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Mayo ClinicNot yet recruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Mayo ClinicRecruitingOropharyngeal Human Papillomavirus-Positive Squamous Cell CarcinomaUnited States
-
Mayo ClinicRecruitingBreast Cancer | Breast Carcinoma | Breast Cancer FemaleUnited States